Skip to main content
Have a personal or library account? Click to login
Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects Cover

Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects

PRILOZI
Volume 43 (2022): Issue 1 (March 2022)
By: Ana Vavlukis,  Marija Vavlukis,  Kristina Mladenovska,  Aleksandar Dimovski,  Natàlia Muñoz-García,  Victoria de Santisteban Villaplana,  Teresa Padro and  Lina Badimon  
Open Access
|Apr 2022
Articles in this issue
DOI: https://doi.org/10.2478/prilozi-2022-0007 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 65 - 75
Published on: Apr 22, 2022
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
CVD risk,
rosuvastatin,
LDL-oxidation,
HDL antioxidative capacity
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2022 Ana Vavlukis, Marija Vavlukis, Kristina Mladenovska, Aleksandar Dimovski, Natàlia Muñoz-García, Victoria de Santisteban Villaplana, Teresa Padro, Lina Badimon, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 43 (2022): Issue 1 (March 2022)
Previous article
Next article